| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142286 Cyclic hydroxylamine as psychoactive compounds |
| 06/29/2006 | US20060142276 Therapeutic agent for senile dementia |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142201 amino acid sequence containing Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; prophylaxis; neuropathic pain, inflammation, incontinence, cardiovascular conditions |
| 06/29/2006 | US20060142194 Methods and compounds for treating brain amyloidosis |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141449 Yeast screens for treatment of human disease |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140950 Using interleukin-23 modulators to treat and prevent nervous system, gastrointestinal and autoimmune disorders |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140932 Human il-1 beta antagonists |
| 06/29/2006 | US20060140866 measuring the accuracy of NMDA injection into a mouse brain comprising co-injecting methylene blue |
| 06/29/2006 | DE112004001368T5 Produkt Product |
| 06/29/2006 | DE102004061503A1 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases |
| 06/29/2006 | DE102004061288A1 New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease |
| 06/29/2006 | CA2592468A1 Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 06/29/2006 | CA2592464A1 Tricyclic .delta.-opioid modulators |
| 06/29/2006 | CA2592462A1 Tricyclic delta-opioid modulators |
| 06/29/2006 | CA2592442A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | CA2592411A1 Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders |
| 06/29/2006 | CA2592407A1 Methods of treating pain |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2592158A1 Methods of modulating the activities of alpha7 nicotinic acetylcholine receptor |
| 06/29/2006 | CA2591963A1 Tricyclic o-opioid modulators |
| 06/29/2006 | CA2591889A1 Treatment for severe melancholic depression with epa |
| 06/29/2006 | CA2591817A1 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 06/29/2006 | CA2591813A1 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 06/29/2006 | CA2591810A1 Chroman derivatives and uses thereof in the treatment of cns disorders |
| 06/29/2006 | CA2591800A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 06/29/2006 | CA2591793A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | CA2591766A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2591304A1 Compositions and methods relating to anti-igf-1 receptor antibodies |
| 06/29/2006 | CA2591125A1 Pyrazolo[1,5-a]pyrimidine adenosine a2a receptor antagonists |
| 06/29/2006 | CA2590155A1 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| 06/29/2006 | CA2589988A1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 06/29/2006 | CA2589671A1 1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar affect |
| 06/29/2006 | CA2588966A1 Cladribine regimen for treating multiple sclerosis |
| 06/29/2006 | CA2588028A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674566A1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 06/28/2006 | EP1674456A2 Substituted alpha-halo-beta-keto-pyridinylpropanoates |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674446A1 A method of preparing memantine hydrochloride |
| 06/28/2006 | EP1674103A1 Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands |
| 06/28/2006 | EP1674102A1 Use of flibanserin in the treatment of sexual disorders |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674087A1 Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| 06/28/2006 | EP1673987A1 Temporally meal menu for infants |
| 06/28/2006 | EP1673439A2 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 06/28/2006 | EP1673372A1 Non-amide nonanes |
| 06/28/2006 | EP1673371A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673367A1 Fused lactam compounds |
| 06/28/2006 | EP1673366A1 1-"2-(4-hydroxyphenyl)-2-hydroxyethyl]-piperidin-4-ol compounds as nmda receptor antagonists |
| 06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1492539B1 Statin therapy for enhancing cognitive maintenance |
| 06/28/2006 | EP1440143B1 Device with recessed tracks for forming a cellular network |
| 06/28/2006 | EP1401812B1 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| 06/28/2006 | EP1395261B1 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1242066B1 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1040185B9 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2006 | EP1007053B1 Treatment of pain |
| 06/28/2006 | EP0936919B1 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 06/28/2006 | CN1795207A Anti-amyloid antibodies, compositions, methods and uses |
| 06/28/2006 | CN1795196A Agent for repairing corneal sensitivity containing amide compound |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795158A Compounds useful in the therapy of alzheimer's disease and formulations containing them |
| 06/28/2006 | CN1795005A Medicine health-care usage of globefish I collagen extration and preparing process thereof |
| 06/28/2006 | CN1794999A Remedy for nerve damage |
| 06/28/2006 | CN1794997A 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | CN1794992A Method for treating mild cognitive impairment and for preventing or delaying alzheimeracoes disease |
| 06/28/2006 | CN1793169A Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
| 06/28/2006 | CN1792254A Health-care food contg. giant salamander, and its production method |
| 06/28/2006 | CN1261589C A beta-peptide screening method |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261414C Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
| 06/28/2006 | CN1261412C Indole derivatives as COXII inhibitors |
| 06/28/2006 | CN1261158C Application of growth hormone for preparation medicine with induced nerve protection function |
| 06/28/2006 | CN1261153C Drug addiction stopping medicine for opium medicine addict |
| 06/28/2006 | CN1261124C Sobering electuary |
| 06/28/2006 | CN1261120C Extracting method of Lucid ganoderma extract with effect for relieving or neutralizing alcohol |
| 06/28/2006 | CN1261111C Preparation method of oral medicine for curing depression |
| 06/28/2006 | CN1261105C Encephalic proteolytic products of compound Piracetam and its preparation method |
| 06/28/2006 | CN1261104C Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 06/28/2006 | CN1261096C Compound preparation of reveratrol and application |
| 06/28/2006 | CN1261095C Brain, spinal and nerve injure treatment |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067661 useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |